January 18, 2017

Ironshore Pharmaceuticals Completes US$200 Million Financing

Goodmans LLP represented Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., in the completion of a US$200 million private placement of Senior Secured Notes due 2024. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction.

The proceeds from the financing will provide the necessary resources for Ironshore to complete its evolution from a research and development organization to a fully integrated pharmaceutical company with a world-class Medical Affairs function. The proceeds will also fund pre-commercialization marketing strategies and tactics as well as commercial launch activities for HLD200, a new drug that manages attention deficit hyperactivity disorder (ADHD) which is under review and awaiting approval by the U.S. Food and Drug Administration.

A prominent player in REITs and SPAC-related offerings, also bearing an impressive record in cross-border and cannabis-related matters. — The Legal 500 Canada
Clients note, "They have an exceptional ability to understand the root of the issue and figure out realistic, step-by-step approaches to solve problems." — Chambers Canada
A distinguished practice valued for advising major REITs and financial institutions on innovative capital markets transactions. — Chambers Canada
On the Capital Markets group, one client says, "deep strength and expertise at all levels...nothing can replace stability and the fact that I have worked with Goodmans on both sides of the table since the early 2000’s." — Legal 500 Canada
One interviewee reported, "The Goodmans team as a whole is excellent," adding: "The lawyers are very responsive and get the job done. It is of great assurance to have them as our legal advisers." — Chambers Canada
Clients comment Goodmans Capital Markets team has "Deep experience, based upon decades of leadership in the sector." — IFLR1000
A client notes, "The lawyers that I have worked with at Goodmans are extremely professional, knowledgeable, creative and excellent service providers. The matters that we have worked on were extremely complicated and required high level of ability to combine understanding of our business objectives with legal analysis." — IFLR1000
Clients note the team's "institutional knowledge is very deep" and stated: "It's like they're part of the team they work with. They're extremely responsive." — Chambers Global

Practices

Industries

Ironshore Pharmaceuticals Completes US$200 Million Financing

Site Search

Ironshore Pharmaceuticals Completes US$200 Million Financing

Expertise

Featured Work